This was the stock's second consecutive day of losses.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

At the insurer's investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — ...

Humana leaders asserted at the company’s investor day Monday that there’s still money to be made on Medicare Advantage ...

Top officials in the Department of Health and Human Services (HHS) are touting a multipronged effort from major payers to ...

Humana, the second-largest Medicare Advantage insurer in the country, is turning to a familiar strategy to boost ...

UnitedHealthcare, Blue Cross Blue Shield and other health insurers plan fixes to prioer authorization, a common source of ...

Millions of Americans face delayed or denied healthcare due to insurance company bureaucracy. Mr. Funk was the managing ...

This was the stock's fourth consecutive day of gains.

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Health insurers accounting for roughly 75% of U.S. patients signed an industry-led pledge this week for improving patient ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks. Learn more about HUM stock here.